IRIS
PETTORRUSO, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.420
AS - Asia 4.077
EU - Europa 3.572
SA - Sud America 670
Continente sconosciuto - Info sul continente non disponibili 582
AF - Africa 84
OC - Oceania 11
Totale 18.416
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.173
SG - Singapore 1.777
IT - Italia 1.353
CN - Cina 857
BR - Brasile 541
VN - Vietnam 523
RU - Federazione Russa 427
IE - Irlanda 396
DE - Germania 340
SE - Svezia 302
BD - Bangladesh 249
HK - Hong Kong 161
GB - Regno Unito 141
TR - Turchia 141
CA - Canada 119
IN - India 113
FI - Finlandia 112
UA - Ucraina 97
FR - Francia 91
MX - Messico 77
NL - Olanda 62
ES - Italia 57
AT - Austria 54
AR - Argentina 52
JP - Giappone 42
PL - Polonia 36
IQ - Iraq 31
ZA - Sudafrica 28
KR - Corea 23
ID - Indonesia 22
LT - Lituania 22
EC - Ecuador 16
PK - Pakistan 16
BE - Belgio 15
CO - Colombia 14
CL - Cile 13
JM - Giamaica 13
SA - Arabia Saudita 13
UZ - Uzbekistan 13
IR - Iran 12
VE - Venezuela 12
IL - Israele 11
JO - Giordania 11
KE - Kenya 11
TN - Tunisia 11
CR - Costa Rica 10
EG - Egitto 10
HU - Ungheria 9
MA - Marocco 9
PY - Paraguay 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
GR - Grecia 8
HN - Honduras 8
PH - Filippine 8
RO - Romania 8
AU - Australia 7
UY - Uruguay 7
GT - Guatemala 6
NP - Nepal 6
BG - Bulgaria 5
CH - Svizzera 5
DK - Danimarca 5
DZ - Algeria 5
KZ - Kazakistan 5
AZ - Azerbaigian 4
BO - Bolivia 4
LB - Libano 4
MD - Moldavia 4
TH - Thailandia 4
BY - Bielorussia 3
EU - Europa 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AL - Albania 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CG - Congo 2
CI - Costa d'Avorio 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
LK - Sri Lanka 2
MY - Malesia 2
NG - Nigeria 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
DO - Repubblica Dominicana 1
GA - Gabon 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
Totale 17.827
Salva come PNG Salva come JPEG
Città #
Singapore 1.372
San Jose 1.023
Ashburn 657
Chandler 538
Council Bluffs 503
Dublin 389
Dallas 334
Los Angeles 279
Beijing 245
Munich 206
The Dalles 193
Ho Chi Minh City 172
Santa Clara 167
Princeton 165
Jacksonville 161
New York 151
Hong Kong 143
Rome 131
Milan 121
Hanoi 97
Altamura 77
Atlanta 71
São Paulo 69
Boardman 67
Redondo Beach 66
Buffalo 62
Orem 56
Wilmington 55
Denver 54
Phoenix 54
Izmir 50
Columbus 49
Hefei 49
Moscow 49
Brooklyn 48
Tongling 46
Chicago 45
Montreal 41
Toronto 40
Washington 38
San Francisco 37
Tokyo 37
Chieti 36
Pescara 36
Helsinki 35
Nanjing 35
Silvi 35
Frankfurt am Main 34
Turku 33
Warsaw 30
Lappeenranta 29
Da Nang 28
Camerino 27
Mexico City 27
Nuremberg 27
Stockholm 27
Bologna 26
Boston 26
Vienna 26
Memphis 25
Chennai 24
Dearborn 24
Houston 22
Haiphong 21
Mumbai 21
Düsseldorf 20
Nanchang 20
Seattle 20
Falls Church 19
Florence 19
St Louis 19
Cambridge 18
Dong Ket 18
Seoul 18
Shanghai 18
Amsterdam 17
London 17
Manchester 17
Pune 17
Johannesburg 16
Naples 16
Teramo 16
Brussels 15
Querétaro 15
Turin 15
Xi'an 15
Ankara 14
Baghdad 14
Bari 14
Castignano 14
Ninh Bình 14
Lauterbourg 13
Paris 13
Poplar 13
Ann Arbor 12
Augusta 12
Hải Dương 12
Salvador 12
Tashkent 12
Verona 12
Totale 9.407
Salva come PNG Salva come JPEG
Nome #
The benzydamine experience: a systematic review of benzydamine abuse 1.063
Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants 536
“Purple Drank” (Codeine and Promethazine Cough Syrup): A Systematic Review of a Social Phenomenon with Medical Implications 509
Comparing efficacy of serotonergic, opioidergic, and glutamatergic drugs in gambling disorder: A pooled analysis of response trajectories versus placebo 508
Misuse of Anticholinergic Medications: A Systematic Review 467
Over-the-counter Psychosis: A Systematic Review of the Misuse of Antihistamines, Cough Medicines, and Decongestants and the Risk of Developing Psychosis 391
Exploring peripheral biomarkers in psychostimulant use: A systematic review on neurotrophins, stress-related hormones, oxidative stress molecules and genetic factors 264
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING) 190
Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study 187
Hallucinogen persisting perception disorder: Etiology, clinical features, and therapeutic perspectives 174
Euthymic bipolar disorder patients and EEG microstates: a neural signature of their abnormal self experience? 169
Gambling disorder: Clinical, preventive and organizational implications 169
Transcranial Direct Current Stimulation Reduces Craving in Substance Use Disorders: A Double-blind, Placebo-Controlled Study 168
Cognitive dynamics of intertemporal choice in gambling disorder 160
Characterizing the building blocks of Problematic Use of the Internet (PUI): The role of obsessional impulses and impulsivity traits among Italian young adults 157
Pharmacological treatments in gambling disorder: A qualitative review 156
Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms 149
BDNF concentration and impulsiveness level in post-traumatic stress disorder 144
An open-label pilot trial of a five-day, accelerated rTMS protocol in bipolar II depression 139
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 138
Transcranial Electrical and Magnetic Stimulation (tES and TMS) for Addiction Medicine: A consensus paper on the present state of the science and the road ahead 138
Hypomanic/manic switch after transcranial magnetic stimulation in mood disorders: A systematic review and meta-analysis 137
Gambling disorder and bilateral transcranial direct current stimulation: A case report 134
A Light in the Darkness: Repetitive Transcranial Magnetic Stimulation (rTMS) to Treat the Hedonic Dysregulation of Addiction 129
A Rorschach test study on the personality characteristics of a sample of pathological gamblers compared to healthy controls 126
Suicide and genetic biomarkers: Toward personalized tailored-treatment with lithium and clozapine 126
BDNF serum levels in subjects developing or not post-traumatic stress disorder after trauma exposure. 125
Hopelessness, dissociative symptoms, and suicide risk in major depressive disorder: Clinical and biological correlates 125
Gender Differences in the Psychopathology of Obesity: How Relevant Is the Role of Binge Eating Behaviors? 124
Telepsychiatry and other cutting-edge technologies in COVID-19 pandemic: Bridging the distance in mental health assistance 123
What role for cognitive remediation in the treatment of depressive symptoms? A superiority and noninferiority meta-analysis for clinicians 122
Augmenting pharmacotherapy with neuromodulation techniques for the treatment of bipolar disorder: a focus on the effects of mood stabilizers on cortical excitability 121
Co-occurrence of alcohol use disorder and behavioral addictions: Relevance of impulsivity and craving 120
Problematic Internet use (PIU), personality profiles and emotion dysregulation in a cohort of young adults: trajectories from risky behaviors to addiction 120
Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment 119
Aberrant salience in cannabis-induced psychosis: a comparative study 117
Appropriately Tuning Stochastic-Psychometric Properties of the Balloon Analog Risk Task 117
Addiction biotypes: a paradigm shift for future treatment strategies? 116
Amantadine in the treatment of Pathological Gambling: a case report 116
Dopaminergic and clinical correlates of high-frequency repetitive transcranial magnetic stimulation in gambling addiction: a SPECT case study 116
Recovering from depression with repetitive transcranial magnetic stimulation (rTMS): a systematic review and meta-analysis of preclinical studies 116
Beyond the efficacy of transcranial magnetic stimulation in peripartum depression: A systematic review exploring perinatal safety for newborns 114
Exploring dopaminergic transmission in gambling addiction: A systematic translational review 114
A Possible Next Covid-19 Pandemic: The Violence Against Women and Its Psychiatric Consequences 113
Impact of sleep disorders and disease duration on neurotrophins levels in cocaine use disorder 112
Psychopathological Burden and Quality of Life in Substance Users During the COVID-19 Lockdown Period in Italy 112
Repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex may improve symptoms of anhedonia in individuals with cocaine use disorder: A pilot study 110
Better Together? Coupling Pharmacotherapies and Cognitive Interventions With Non-invasive Brain Stimulation for the Treatment of Addictive Disorders 109
Overcoming treatment-resistant depression with machine-learning based tools: a study protocol combining EEG and clinical data to personalize glutamatergic and brain stimulation interventions (SelecTool Project) 108
Staying connected: An umbrella review of meta-analyses on the push-and-pull of social connection in depression 106
Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis 106
Non-invasive brain stimulation targets and approaches to modulate gambling-related decisions: A systematic review 105
From a cycle to a period: the potential role of BDNF as plasticity and phase-specific biomarker in cocaine use disorder 105
Suicidal Behavior and Club Drugs in Young Adults 105
Enhanced peripheral levels of BDNF and proBDNF: elucidating neurotrophin dynamics in cocaine use disorder 104
The aftermath of trauma on resting state source-level MEG microstate dynamics 104
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data 104
Connected minds in disconnected bodies: Exploring the role of interoceptive sensibility and alexithymia in problematic use of the internet 103
Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice 103
Craving and Other Transdiagnostic Dimensions in Addiction: Toward Personalized Neuromodulation Treatments 103
Multiple Sessions of High-Frequency Repetitive Transcranial Magnetic Stimulation as a Potential Treatment for Gambling Addiction: A 3-Month, Feasibility Study 103
Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and Treatment 103
Craving variations in patients with substance use disorder and gambling during COVID-19 lockdown: The Italian experience 103
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation 103
When neuromodulation met control theory 102
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study) 102
Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity 102
Neural correlates of cognitive control in gambling disorder: a systematic review of fMRI studies 102
Duration of untreated disorder and cannabis use: An observational study on a cohort of young italian patients experiencing psychotic experiences and dissociative symptoms 102
rTMS Reduces Psychopathological Burden and Cocaine Consumption in Treatment-Seeking Subjects With Cocaine Use Disorder: An Open Label, Feasibility Study 101
Combining Dopamine Agonists With Accelerated Repetitive Transcranial Magnetic Stimulation: A Case of Successful Treatment of Resistant Depression 100
Investigating brain network dynamics in state-dependent stimulation: A concurrent electroencephalography and transcranial magnetic stimulation study using hidden Markov models 100
Allostasis as a conceptual framework linking bipolar disorder and addiction 100
Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History 99
Intranasal esketamine as tool for rapid cycling bipolar disorder: A case report of successful mood stabilization 98
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study 98
Dopaminergic dysfunction in the left putamen of patients with major depressive disorder 98
Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study 98
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 97
Mechanistic insights into the efficacy of memantine in treating certain drug addictions 97
High-Risk Gaming Is Associated with Frequent Substance Use: An Exploratory Survey among Young Adults 97
Management of aripiprazole-induced tardive Pisa syndrome: a case report and literature review 96
Striatal presynaptic dopaminergic dysfunction in gambling disorder: A 123 I-FP-CIT SPECT study 95
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature 95
Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels' Decline: A Narrative Review 94
Gender-related psychopathology in opioid use disorder: Results from a representative sample of Italian addiction services 94
Substance Related Exogenous Psychosis: A Post-Modern Syndrome 94
Trazodone add-on in COVID-19-related selective serotonin reuptake inhibitor-resistant post-traumatic stress disorder in healthcare workers: Two case reports 94
Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine 92
Efficacy of Noninvasive Brain Stimulation on Borderline Personality Disorder Core Symptoms: A Systematic Review 92
Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study 91
New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances 91
Anhedonia across borders: Transdiagnostic relevance of reward dysfunction for noninvasive brain stimulation endophenotypes 91
Transcranial direct current stimulation for Phantom Limb Pain circuitopathy: Efficacy and safety in a patient with a cardiac defibrillator 91
Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature 90
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group 89
Club Drugs and Psychiatric Outcomes: A Descriptive Case Series from Spain 89
Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience) 89
Suicide in Healthcare Workers: Determinants, Challenges, and the Impact of COVID-19 88
Brexpiprazole as a new approach of treatment in somatization disorder 88
Totale 14.313
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.183
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022437 0 0 6 46 22 14 14 44 35 32 60 164
2022/20231.532 120 225 103 146 127 294 88 122 211 16 50 30
2023/20241.080 65 62 93 44 87 253 156 86 35 48 42 109
2024/20252.796 190 407 266 124 75 118 179 134 282 255 397 369
2025/20267.902 617 313 664 931 769 440 941 549 889 649 737 403
2026/20273.574 1.091 1.510 973 0 0 0 0 0 0 0 0 0
Totale 18.416